{"name":"Arisan Therapeutics, Inc.","slug":"arisan-therapeutics-inc","ticker":"","exchange":"","domain":"arisan.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ARN-75039","genericName":"ARN-75039","slug":"arn-75039","indication":"Other","status":"phase_1"},{"name":"ARN-75039 oral capsules","genericName":"ARN-75039 oral capsules","slug":"arn-75039-oral-capsules","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ARN-75039","genericName":"ARN-75039","slug":"arn-75039","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ARN-75039 oral capsules","genericName":"ARN-75039 oral capsules","slug":"arn-75039-oral-capsules","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPZVFKS0llbFdXT2QyWXN6Yk93WEp3WDV5V3JUc2ZCUTM0ZTl1dksyRGZnOURIbzB1LXU2cjk3V2lyY2xpdGQzT1dGU3Q1Ukl3VDdZWkVlMWlMV1JqUmNsNWRXbUhXWHhNdXNPS2F1bnlIS2p0VC1fV1RHZ01fTWQwWnVrWjh4VTVsYk91VFVCZ201cjhwLThPQjFQemE2NUxXU0NWRmY3MWRPMFJRR0VTNk5iWlBQY3dhQWJraVkzS2lOQ2w5VXozUHo5cS1DdDVBNDBLeVY1Zmh2U2pfbFpCQmZWRXNvMGJFUzJwaHY5b0s4a2VFUjdLY2ZwRkdTNDhm?oc=5","date":"2024-10-17","type":"pipeline","source":"GlobeNewswire","summary":"Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight - GlobeNewswire","headline":"Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}